Skip to main content
  • Advertise
    Want to Advertise with Us?
    Conquer welcomes advertising and sponsorship collaborations with reputable companies offering high-quality products and services to people affected by cancer.
  • Affiliated Brands
    Academy of Oncology Nurse & Patient Navigators
    The Academy of Oncology Nurse & Patient Navigators (AONN+) is the largest national specialty organization dedicated to improving patient care and quality of life by defining, enhancing, and promoting the role of oncology nurse and patient navigators. Our organization of over 8,900 members was founded in May 2009 to provide a network for all professionals involved and interested in patient navigation and survivorship care services to better manage the complexities of the cancer care treatment continuum for their patients. We view our organization as one consisting of “professional patient advocates” and, to that end, we support and serve our members.
    Journal of Oncology Navigation & Survivorship
    The Journal of Oncology Navigation & Survivorship (JONS) promotes reliance on evidence-based practices in navigating patients with cancer and their caregivers through diagnosis, treatment, and survivorship. JONS also seeks to strengthen the role of nurse and patient navigators in cancer care by serving as a platform for these professionals to disseminate original research findings, exchange best practices, and find support for their growing community.
    The Oncology Nurse-APN/PA
    The Oncology Nurse-APN/PA (TON) provides coverage of the wide spectrum of oncology-related events, trends, news, therapeutics, diagnostics, organizations, and legislation that directly affect hematology/oncology nurses and advanced practitioners involved in healthcare delivery and product utilization. The scope and coverage include a unique presentation of news and events that are shaping the care of patients with cancer.
  • Healthcare Providers
  • Contribute

Drugs for Pancreatic Cancer

Abraxane (paclitaxel protein-bound particles; albumin-bound)

Drug company: Bristol Myers Squibb

Bristol Myers Squibb Access Support offers 2 financial assistance programs for patients using Abraxane:

BMS Oncology Co-Pay Assistance Program

Bristol Myers Squibb Patient Assistance Foundation

Lynparza (olaparib) Capsules/Tablets

Drug company: AstraZeneca

AstraZeneca offers 2 financial assistance programs for patients who have been prescribed Lynparza:

Lynparza Co-pay Savings Program

AZ&Me Prescription Savings Program

Onivyde (irinotecan liposome injection)

Drug company: Ipsen

Ipsen Cares offers 2 financial assistance programs for patients using Onivyde:

Onivyde Copay Program

Ipsen Cares Patient Assistance Program

Tarceva (erlotinib) Tablets

Drug company: Genentech

Genentech Oncology offers 2 financial assistance program for patients using Tarceva:

Genentech Oncology Co-pay Assistance Program

Genentech Patient Foundation

Table. Drugs Prescribed for Pancreatic Cancer

  • Drug name (generic name)
  • Drug company
  • Indications
  • Patient support services
    Drug name (generic name)
  • Lynparza (olaparib) Capsules/Tablets
  • Drug company
  • AstraZeneca
  • Indication
  • Maintenance treatment of patients with metastatic pancreatic cancer and deleterious or suspected deleterious germline BRCA mutation, as detected by an FDA-approved test, in adults whose disease had not progressed after 16 weeks or more of platinum-based chemotherapy in the first-line setting
  • Patient support services
  • Lynparza Co-pay Savings Program

    AZ&Me Prescription Savings Program

Report Broken Links

Have you encountered a problem with a URL (link) on this page not working or displaying an error message?

Help us fix it! Report broken links here.

Report Broken Link